Influence of Intra-abdominal Ropivacaine 0.5% Spray on Postoperative Analgesia in Laparoscopic Surgery.

Not Applicable

• Conditions: Pain, Acute
• Interventions: Drug: Ropivacaïne 0,5% for appendectomy or cholecystectomy surgery

• Registration Number: NCT05173090
• Lead Sponsor: University of Liege

Brief Summary

Assessing postoperative pain after ropivacin 0.5% spray in the abdominal cavity during laparoscopic surgery.

Detailed Description

Not available

Study Timeline

• Status Verified: 2021-11
• Study First Submitted: 2021-11-29
• Study First Submitted QC: 2021-12-10
• Last Update Submitted: 2021-12-10
• Study First Posted: 2021-12-29
• Last Update Posted: 2021-12-29
• Study Start: 2022-01-15
• Primary Completion: 2022-06-30
• Study Completion: 2022-07-30

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 120

Inclusion Criteria

• Appendectomy or cholecystectomy surgery

Exclusion Criteria

• Allergy to local anesthetics
• Intolerance to tramadol HCl
• Patient with peritonitis
• Pregnant women
• Surgery without laparoscopy
• Chronic pain before the operation

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Ropivacaïne 0,5%	Ropivacaïne 0,5% for appendectomy or cholecystectomy surgery	3 mg/kg of ropivacaine 0.5% sprayed into the abdominal cavity
NaCl 0,9%	Ropivacaïne 0,5% for appendectomy or cholecystectomy surgery	NaCl 0,9% sprayed into the abdominal cavity

Primary Outcome Measures

Name	Time	Method
Patient's pain	During appendectomy and cholecystectomy surgery	The patient's satisfaction was assessed by visual analog scale, ranging from one (worse outcome )to four (better outcome